NovaShunt, AG: Series B $25M

Posted in I - Series B, Q - 1Q11, R - INTERNATIONAL, X - Device (Pump)

NovaShunt (Switzerland) a clinical-stage medical device company focused on an implantable ascites pump system for patients suffering from liver cirrhosis, certain cancers and congestive heart failure, closed a $25M Series B financing. Participants include BioMedInvest, Entrepreneurs Fund, Capricorn Health-tech Fund, NeoMed and VI Partners.

Mar

2010

Tandem Diabetes Care, Inc.: Series C $30.8M

Posted in I - Series C, Q - 1Q10, R - WEST, X - Device (Diabetes), X - Device (Pump), XX - CA

Tandem Diabetes Care (San Diego, CA) a development-stage medical device company focused on insulin pump technology, closed a $30.8M Series C financing, bringing the total round to $52.3M. Participants include HLM Venture Partners, Domain Associates, TPG Biotech, Delphi Ventures and Kearny Venture Partners.

Jan

2009

InSet Technologies, Inc.: Series B $25M

Posted in I - Series B, Q - 1Q09, R - NORTH EAST, X - Device (Pump), XX - NJ

InSet Technologies (Mt. Olive, NJ) an early-stage company developing implantable pumps delivering targeted medications directly to the spinal cord (intrathecal space) to achieve potentially improved functional relief with a dramatic reduction in the side effects from high doses of drugs for chronic pain, closed a $25M Series B financing. Participants include Clarus Ventures and [...]

to top of page...